PRKAG2 Cardiomyopathy: A Case-Control Study on the Diagnostic Yield Of Histopathology and Ultrastructural Analysis

Kinulpe Honorato-Sampaio1, Carla de Oliveira2, Stanley de Almeida Araújo3

  • 1Faculdade de Medicina, Universidade Federal do Vale do Jequitinhonha e Mucuri, Diamantina, MG - Brasil.

Insights

Histopathological examination of PRKAG2 cardiomyopathy reveals significant cardiomyocyte enlargement and abundant cytosolic glycogen accumulation, distinguishing it from other heart conditions. These findings aid in diagnosing PRKAG2 cardiomyopathy.

Area of Science:

  • Cardiovascular Pathology
  • Molecular Cardiology
  • Genetic Heart Diseases

Background:

  • Histopathological data on PRKAG2 cardiomyopathy are currently fragmented.
  • Understanding PRKAG2 cardiomyopathy's cardiac pathology is crucial for diagnosis and management.

Purpose of the Study:

  • To systematically evaluate cardiac pathological features in a large cohort of PRKAG2 cardiomyopathy patients.
  • To compare the diagnostic utility of histopathology with genetic sequencing for PRKAG2 cardiomyopathy.

Main Methods:

  • Observational, cross-sectional, case-control study.
  • Endomyocardial biopsies analyzed via H&E, PAS, Masson's trichrome staining, and transmission electron microscopy.
  • Comparison between 18 PRKAG2 cardiomyopathy patients and 11 heart transplant controls.

Main Results:

  • PRKAG2 cardiomyopathy hearts showed cardiomyocyte enlargement, vacuolization, minimal fibrosis, and no inflammation.
  • Transmission electron microscopy revealed extensive cytosolic glycogen accumulation, primarily perinuclear.
  • Glycogen accumulation was consistently present in PRKAG2 patients and absent in controls.

Conclusions:

  • Histological and ultrastructural analysis of endomyocardial biopsies reveals distinct features of PRKAG2 cardiomyopathy.
  • These findings aid in the pathological diagnosis of PRKAG2 cardiomyopathy.
  • Histopathology offers valuable diagnostic insights complementing genetic testing.
Abstract

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
430
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
640
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
746